42 results Stibbe named ‘Belgium Patent Disputes Firm of the Year' by Managing IP We are delighted to have been named ‘Belgium Patent Disputes Firm of the Year’ for the second year in a row at the annual Managing IP Awards ceremony held on 21 June 2023. Keeping up with Belgian patent litigation: Year case law review 2022 Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law. International Comparative Legal Guide - Patents Law & Regulations - Belgium Chapter The ICLG to Patents Law & Regulations covers common issues in patent laws and regulations – including enforcement, amendment, licensing, term extension, and prosecution. Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby. Stibbe named ‘Belgian Trademark Contentious Firm of the Year' by Managing IP We are delighted to have been named 'Belgian Trademark Contentious Firm of the Year' at the annual Managing IP Awards ceremony last night. Stibbe advises Blackstone Stibbe assisted Blackstone with the acquisition of Desotec. Overview of the most important decisions rendered in Belgian patent litigation cases in 2020 Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law. Stibbe named ‘Belgium Patent Contentious Firm of the Year' by Managing IP We are delighted to have been named ‘Belgium Patent Contentious Firm of the Year’ at the annual Managing IP Awards ceremony on 15 June 2022. Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan. Keeping up with Belgian patent litigation: Year case law review 2023 Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises Qorvo Stibbe advised Nasdaq listed Qorvo, a leading provider of core technologies and RF solutions for mobile, infrastructure and defense applications, on its acquisition of Netherlands-based privately-held GreenPeak Technologies. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe advises multinational groups Stibbe advised various multinational groups on IP rights and R&D tax aspects, restructuring, commercial structure, and transfer pricing. Stibbe advises trading and recycling companies Stibbe advised trading and recycling companies on the drafting of agreements such as confidentiality agreements, license agreements, and partnership agreements. Pagination Current page 1 Page 2 Page 3 Next page
Stibbe named ‘Belgium Patent Disputes Firm of the Year' by Managing IP We are delighted to have been named ‘Belgium Patent Disputes Firm of the Year’ for the second year in a row at the annual Managing IP Awards ceremony held on 21 June 2023.
Keeping up with Belgian patent litigation: Year case law review 2022 Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law.
International Comparative Legal Guide - Patents Law & Regulations - Belgium Chapter The ICLG to Patents Law & Regulations covers common issues in patent laws and regulations – including enforcement, amendment, licensing, term extension, and prosecution.
Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby.
Stibbe named ‘Belgian Trademark Contentious Firm of the Year' by Managing IP We are delighted to have been named 'Belgian Trademark Contentious Firm of the Year' at the annual Managing IP Awards ceremony last night.
Overview of the most important decisions rendered in Belgian patent litigation cases in 2020 Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law.
Stibbe named ‘Belgium Patent Contentious Firm of the Year' by Managing IP We are delighted to have been named ‘Belgium Patent Contentious Firm of the Year’ at the annual Managing IP Awards ceremony on 15 June 2022.
Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.
Keeping up with Belgian patent litigation: Year case law review 2023 Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises Qorvo Stibbe advised Nasdaq listed Qorvo, a leading provider of core technologies and RF solutions for mobile, infrastructure and defense applications, on its acquisition of Netherlands-based privately-held GreenPeak Technologies.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe advises multinational groups Stibbe advised various multinational groups on IP rights and R&D tax aspects, restructuring, commercial structure, and transfer pricing.
Stibbe advises trading and recycling companies Stibbe advised trading and recycling companies on the drafting of agreements such as confidentiality agreements, license agreements, and partnership agreements.